Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
TolerRx, Inc.
Download detailed PDF Members: We are a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with immunological diseases. TolerRx has a development pipeline which includes two humanized antibodies that are in clinical trials for new-onset type 1 diabetes, psoriasis, and cutaneous lupus erythematosus. We also have ongoing research and development programs focused on generating new monoclonal antibody and small molecule products for the treatment of immunological diseases.
This page has been viewed 631 times since April 2007, the link to the organisation's website has been followed 106 times Recent Search Terms used to find this page: tolerx leases | tolerrx | tolerrx | ToleRx Inc | tolerrx inc | . Search for more companies in Cambridge Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for TolerRx, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|